Vision Guided Robotic Systems

Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next “Access-Ability Live by MBOT” Webinar Series

Retrieved on: 
Tuesday, January 31, 2023
Columbia University Irving Medical Center, NewYork-Presbyterian Hudson Valley Hospital, Safety, Navigation, Vision Guided Robotic Systems, Health, FIH, PCI, Web conferencing, Physician, Patient, Q&A, Public, Time-invariant system, Interventional cardiology, Clinical trial, Siemens Healthineers, Faculty, Cardiology, Corindus Vascular Robotics, Associate, Medical device, Medicine

HINGHAM, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic System, the first single-use endovascular robotic system, announced the next episode of its highly successful “Access-Ability Live by MBOT” webinar, which is intended for all stakeholders interested in the endovascular robotic space and will be held on Wednesday, February 8, 2023, at 1:00pm ET. It will be hosted by the Company’s Chief Medical Officer, Dr. Eyal Morag.

Key Points: 
  • It will be hosted by the Company’s Chief Medical Officer, Dr. Eyal Morag.
  • He is also a faculty member at the Cardiovascular Research Foundation in New York.
  • Dr. Weisz, who has a particular interest in current and innovative technologies in cardiovascular medicine, is an early adopter of robotic-enhanced coronary interventions, as well as navigation and positioning technologies.
  • The “Access-Ability Live by MBOT” webinar series focuses on key topics in the healthcare and endovascular space.

Medical Robots Global Market Report 2022: Sector to Reach $21.65 Billion by 2026 at a CAGR of 18.1%

Retrieved on: 
Monday, January 16, 2023
Benchmark, Diligence, Johnson & Johnson, Cleveland Clinic, Hospital, Create, Diligent Corporation, Lung cancer, Medicine, Agriculture, Lung, Growth, Cleveland, Patient, Coronavirus, Moxi, Vision Guided Robotic Systems, Acquisition, Abdomen, Medical device, Marketing

DUBLIN, Jan. 16, 2023 /PRNewswire/ -- The "Medical Robots Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 16, 2023 /PRNewswire/ -- The "Medical Robots Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.
  • The regions covered in the medical robot market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
  • The rising demand for precise and proper laparoscopic operations is expected to propel the growth of the medical robot market going forward.
  • Therefore, the rising demand for precise and proper laparoscopic operations is driving the growth of the medical robot market.

Medical Robots Global Market Report 2022: Rising Demand for Precise and Proper Laparoscopic Operations Bolsters Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Surgery, Health, Robotics, Technology, Health Technology, Benchmark, Diligence, Johnson & Johnson, Cleveland Clinic, Hospital, Create, Diligent Corporation, Lung cancer, Medicine, Agriculture, Lung, Growth, Cleveland, Patient, Coronavirus, Moxi, Vision Guided Robotic Systems, Acquisition, Abdomen, Medical device, Marketing

The "Medical Robots Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Robots Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.
  • The rising demand for precise and proper laparoscopic operations is expected to propel the growth of the medical robot market going forward.
  • As a result, there is rising demand for precise and proper laparoscopic operations that boost market growth.
  • Therefore, the rising demand for precise and proper laparoscopic operations is driving the growth of the medical robot market.

Two Hitachi Group Companies to Merge to Expand Robotic SI Business in Japan and ASEAN Countries

Retrieved on: 
Monday, January 30, 2023
KEC, Ageing, COVID-19, Automation, Environment, ASEAN, Digital technology, Organization, TSE, AI, Secretary General of the ASEAN, News, Human, OT, Vision Guided Robotic Systems, Robotics, PC Open Architecture Developers' Group, 3D printing, Waste management, Electric power industry

At the same time, Hitachi will unite its domestic robotic SI business resources, including the companies' customer bases, expertise and human capital, to enhance sales and development functions and to increase the business efficiency.

Key Points: 
  • At the same time, Hitachi will unite its domestic robotic SI business resources, including the companies' customer bases, expertise and human capital, to enhance sales and development functions and to increase the business efficiency.
  • Hitachi will also strengthen the collaboration with JR Automation, which operates its robotic SI business mainly in North America and Europe, and Hitachi Automation to expand its ability to provide full turnkey solutions.
  • (11) Subsequently, KEC and the robotic SI business of Hitachi Industrial Equipment Systems were reorganized and integrated, becoming Hitachi Automation in April 2022.
  • Now, Hitachi has decided to merge Hitachi Automation with Kyoto Robotics to increase the competitiveness of the robotic SI business in Japan and ASEAN countries.

Microbot Medical Announces MedTech Industry Veteran Joe Mullings will Moderate the Next ‘Access-Ability Live by MBOT’ Webinar

Retrieved on: 
Friday, January 6, 2023
Knowledge, Dragonfly, Attention, Physician, Q&A, Vision Guided Robotic Systems, Health

HINGHAM, Mass., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic System, the first single-use endovascular robotic system, announced that Joe Mullings, a renowned and successful leader in the medtech space, will moderate the next Access-Ability Live by MBOT webinar. The webinar episode will be held on Tuesday, January 10, 2023, at 2:00pm ET (11am PT), and will feature proven medical device entrepreneurs and recognized pioneers in the surgical robotics field.

Key Points: 
  • Joe Mullings is Chairman & CEO of The Mullings Group Companies, including TMG Search, Dragonfly Stories & TMG360 Media.
  • The search firm is responsible for more than 8,000 successful searches in the medtech / healthtech industry working with over 800 companies ranging from multi-billion-dollar organizations to emerging tech startups.
  • Dragonfly Stories is the media production company behind the 7x Telly Award-Winning video docuseries, “TrueFuture”, of which Joe is the host.
  • The Access-Ability Live by MBOT webinar series focuses on key topics in the healthcare and endovascular space.

Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next “Access-Ability Live by MBOT” Webinar Series

Retrieved on: 
Wednesday, December 14, 2022
Coronavirus Scientific Advisory Board (Turkey), Physician, Intellectual property, Robotics, Failure, Security (finance), SAB, Cancer, Maintenance, Moyamoya disease, Consultant, Federal, Web conferencing, Vision Guided Robotic Systems, Windows Live Personalized Experience, Health, Growth, Organization, Research, History, COVID-19, Patient, Q&A, Medical device, Microbotics

HINGHAM, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic System, the first fully disposable endovascular robotic system, announced that following the success of the first episode of its newly launched “Access-Ability Live by MBOT,” the next episode which is geared toward all stakeholders interested in the endovascular robotic space, will be held on Wednesday, December 21, 2022 at 1:00pm ET, and hosted by the Company’s Chief Medical Officer, Dr. Eyal Morag.

Key Points: 
  • The “Access-Ability Live by MBOT” webinar series focuses on key topics in the healthcare and endovascular space.
  • Microbot’s current proprietary technological platforms provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP).
  • Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.
  • Certain guests of Access-Ability are members of the Scientific Advisory Board (SAB) of Microbot or paid consultants of Microbot, and have received compensation for their services to Microbot.

Global Medical Robotic Systems Market Report (2022-2027): Increasing Government Initiatives for Improving Awareness About Diagnosis and Treatment Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 15, 2022
Practice Management, Technology, Health, Radiology, Robotics, Health Technology, Medical Devices, Infectious Diseases, Apps, Applications, Surgery, COVID-19, Observation, Porter's five forces analysis, Others, Cobalt therapy, Sofie (surgical robot), Ansoff Matrix, Robotics, Robot-assisted surgery, Physical therapy, Neurology, COVID-19, Degenerative disease, Vision Guided Robotic Systems, SWOT, USD, Growth, Investment, Risk, Neglected tropical disease research and development, Market development, Orthopedic surgery, Medical device, Retail, Risk management, Pharmaceutical industry, Cancer, Hospital, Laparoscopy, Geography

Growing Incidences of Diseases Such as Cancer, Neurological Disorders, Orthopedic Surgery, and Cardiovascular Diseases

Key Points: 
  • Growing Incidences of Diseases Such as Cancer, Neurological Disorders, Orthopedic Surgery, and Cardiovascular Diseases
    The Global Medical Robotic Systems Market is segmented based on Type, Applications, and Geography.
  • By Type, the market is classified into Assistive and Rehabilitation Systems, Non-invasive Radiosurgery Robotic Systems, Non-medical Robotics in Hospitals, Prosthetics/Exoskeletons, and Surgical Robots.
  • The report presents a detailed Ansoff matrix analysis for the Global Medical Robotic Systems Market.
  • The report offers a comprehensive evaluation of the Global Medical Robotic Systems Market.

Lab Automation Global Market Report 2022: Amalgamation of AI and Analytical Tools in Laboratory Workflows Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022
Software, Technology, Biotechnology, Health, Vision Guided Robotic Systems, Hospital, Use, Strategic management, Research, Value, Ortho Clinical Diagnostics, Laboratory information management system, LIMS, Collaborative Drug Discovery, Biotechnology, Customer support, Electronic lab notebook, Market share analysis, Business Growth Fund, Reader-response criticism, Research report, Standardization in Lab Automation, HTS, Robotic arm, COVID-19, Growth, Cumulative distribution function, LES, High-throughput screening, Workcell, Luminescence, Automated pipetting system, Royal Belfast Academical Institution, ASRS, EIA, Acquisition, SDMS, ELN, Compound management, Drug discovery, Automation, Automated storage and retrieval system, Economic development, Climate Monitoring and Diagnostics Laboratory, Equipment, Fine chemical, Retail, Software, Application

The Global Lab Automation Market is projected to grow with a significant CAGR in the forecast period.

Key Points: 
  • The Global Lab Automation Market is projected to grow with a significant CAGR in the forecast period.
  • Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities.
  • Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Lab Automation Market.
  • The Off-The-Shelf Automated Workcells is further studied across Post-Analytical Automated Systems, Pre-Analytical Automated Systems, and Total Lab Automation Systems.

CMR Surgical announces more than 100 Versius systems installed globally

Retrieved on: 
Thursday, November 17, 2022
CMR, Urology, Growth, Vision Guided Robotic Systems, Elective surgery, Hospital, GMT, Patient, Wales, CMR Surgical, News, Colorectal surgery, NHS Wales, Cancer, Surgeon, General surgery, Medical device, Vento (motorcycle manufacturer)

CMR Surgical (CMR) the global surgical robotics business today provides an update on progress, as the Company announces it has now installed more than 100 Versius Surgical Robotic Systems commercially.

Key Points: 
  • CMR Surgical (CMR) the global surgical robotics business today provides an update on progress, as the Company announces it has now installed more than 100 Versius Surgical Robotic Systems commercially.
  • CMR has continued to scale-up rapidly and has now installed the next-generation robotic system across Europe, Asia, Australia, Latin America, and the Middle East.
  • Per Vegard Nerseth, Chief Executive Officer of CMR Surgical, comments: This is a significant milestone for CMR as we continue to deliver on our ambitious commercial plans.
  • If you wish to see more, please contact CMR Surgical at:

CMR Surgical announces more than 100 Versius systems installed globally

Retrieved on: 
Thursday, November 17, 2022
CMR, Urology, Growth, Vision Guided Robotic Systems, Elective surgery, Hospital, GMT, Patient, Wales, CMR Surgical, News, Colorectal surgery, NHS Wales, Cancer, Surgeon, General surgery, Medical device, Vento (motorcycle manufacturer)

CMR Surgical (CMR) the global surgical robotics business today provides an update on progress, as the Company announces it has now installed more than 100 Versius Surgical Robotic Systems commercially.

Key Points: 
  • CMR Surgical (CMR) the global surgical robotics business today provides an update on progress, as the Company announces it has now installed more than 100 Versius Surgical Robotic Systems commercially.
  • CMR has continued to scale-up rapidly and has now installed the next-generation robotic system across Europe, Asia, Australia, Latin America, and the Middle East.
  • Per Vegard Nerseth, Chief Executive Officer of CMR Surgical, comments: This is a significant milestone for CMR as we continue to deliver on our ambitious commercial plans.
  • If you wish to see more, please contact CMR Surgical at: